Baltera Robert Jr. 4

What Happened
Robert Baltera Jr., a director of Palisade Bio, was granted 336,904 restricted stock units (RSUs) on June 10, 2026. The filing lists this as an award/grant (transaction code A); no purchase price or cash value is shown because RSUs convert to shares upon vesting rather than being an open-market trade. This is an equity compensation award, not a buy or sell of existing shares.

Key Details

• Transaction date: 2026-06-10 (reported on Form 4 filed 2026-06-18).
• Transaction type/code: Award/Grant (A) — 336,904 RSUs granted.
• Price: N/A for RSU grants (they represent contingent rights to future shares).
• Vesting: RSUs vest in three equal annual installments; the first installment vests on the one-year anniversary of the grant, subject to continuous service.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Timeliness: The Form 4 was filed 8 days after the grant (appears late relative to the two-business-day filing deadline for Form 4).

Context
RSUs are compensation awards that convert to common shares as they vest; they do not represent immediate share ownership or an open-market purchase. Such grants are routine for directors and executives as part of pay/retention packages and do not, by themselves, indicate a buy or sell sentiment. The late filing reduces near-term transparency but does not change the nature of the award.